News archive

Thyroid FNA and the Bethesda System: What possibilities are there to perform molecular tests?

IAC Webinar to be held 27th May 2021 (7AM and repeated at 5PM Central European Summer Time)



Webinar Summary
In 2017 the second edition of The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) was released.

The new version incorporated the re-classification done by the WHO of some thyroid papillary carcinomas into the NIFTP (noninvasive follicular thyroid neoplasm with papillary-like nuclear features), that has implications for the risk of malignancy and for the diagnostic criteria. Moreover, new management options concerning molecular test were introduced for some diagnostic categories.


This webinar will concentrate in the new updates (as in the second edition) of TBSRTC concerning the diagnostic categories and when and how apply molecular test to cytological specimens. Different possibilities available on the marker will be analyzed and compared with test that can be performed in house.



Full Webinar information & booking